Order Center

Use the Order Center to build a Shopping Cart, view Saved Shopping Carts, Recent Orders and Quotes

SDS

Search for SDS (Safety Data Sheet) by Product Number

Oligo Ordering

Custom Products and Services, including DNA oligos (Primers and Probes), RNA, siRNA, Peptide Libraries and AQUA Peptides

Redi-Dri™ for Free-Flowing Hygroscopic Powders

Redi-Dri packaging system eliminates clumping typically noted with many hygroscopic powders and provides a free-flowing, ready-to-use material.

Contáctenos

Customer Service:
Teléfono: 52 722 276 1600
Sin costo: 01800-0075300

Productos Regulados

Lista de productos controlados

Ofertas Especiales

México 2019 -Conozca todas las promociones que lo harán sonreír

Próximos Eventos

Encuentre aquí la información actualizada tanto de los eventos de la industria en lo que participaremos como de nuestros propios eventos

Tu Opinión Es Muy Importante

Participa de Nuestra Encuesta y Podrás Ganar un Fabuloso Premio

News & Information

Darmstadt, Germany - August 19, 2019 Merck KGaA, Darmstadt, Germany Granted 20 CRISPR Patents Total Worldwide

Merck KGaA, Darmstadt, Germany today announced that the European, Israeli, South Korean and U.K. intellectual property offices have issued formal notices allowing seven additional Merck patent application claims covering CRISPR gene-editing technology, bringing the number of patents to 20 worldwide.

Read More
Darmstadt, Germany - August 6, 2019 Merck KGaA, Darmstadt, Germany Acquires BSSN Software to Accelerate Customers’ Digital Transformation in the Lab

Merck KGaA, Darmstadt, Germany has acquired BSSN Software, a Darmstadt, Germany-based laboratory informatics company that makes data more readily accessible for ease of integration, collaboration, analysis and long-term archiving.

Read More
Shanghai, China - July 24, 2019 Merck KGaA, Darmstadt, Germany to Provide BioReliance® End-to-End Solutions to Phanes Therapeutics

Merck KGaA, Darmstadt, Germany today announced the signing of a non-binding Memorandum of Understanding (MoU) with Phanes Therapeutics, Inc. (Phanes) for a collaboration on the development and manufacture of biologics for the treatment of solid tumors.

Read More